Occam Places John Reynders as Chief Data Sciences Officer of Neumora
Neumora Therapeutics, an Arch Venture Partners' investment leveraging ML to develop CNS drugs, emerged from stealth mode in 2021 with $500M in financing.
In 2020, Occam placed John Reynders, PhD, as the company's first Chief Data Sciences Officer. Prior to Neumora, John served as Vice President, data sciences, genomics and bioinformatics at Alexion, where he led the design, building and deployment of data sciences solutions spanning R&D, commercial, strategy and business development. Prior to joining Alexion, John served as the founding Chief Information Officer of Moderna Therapeutics.
Occam Global is a biotech executive search, recruiting, and leadership advisory firm with specialties across technological fields, including Biotech, TechBio, AI-ML, Cell/Gene Therapy, Diagnostics/Genomics, Medical Devices, Research Tools, Digital Health, Alternative Energy, AgTech, EdTech, Robotics as well as adjacencies within Venture Capital and Private Equity. Occam helps build biotech executive leadership teams that meet the demands of the rapidly developing, competitive, and challenging industries it serves. Occam Global recruits leading C-Suite executives and board members for the most exciting and innovative clients across the world with a specific focus on the UK, Continental Europe, the US, and Asia.